BioAlliance Pharma’s muco-adhesive Loramyc (miconazole Lauriad) is already approved in Europe and completed a Phase III clinical trial in the US in immunocompromised patients. BioAlliance’s partnership with NovaMed
The Phase II study was a randomized, double-blind, and placebo-controlled dose-ranging study to evaluate the efficacy and safety of ABT-894 in approximately 200 adults with attention-deficit hyperactivity disorder
Under the agreement, Tikcro will provide BioCancell with $2.5 million in funding at the closing. Of this amount, $2 million will be allocated to a four-year convertible note
Johnson & Johnson’s McNeil Consumer Healthcare unit manufactures the branded treatment, which is also called Cetirizine hydrochloride syrup. Zyrtec syrup is a colorless to slightly yellow syrup containing
The agreement, with an effective date of June 1, 2008 provides MedAssets’s customers access to Dilon’s cornerstone product, The Dilon 6800 gamma camera. The Dilon 6800 performs a
This expanded agreement will continue to offer MedAssets’s customers ICU’s products which provide better patient outcomes and cost reduction as well as cost avoidance, said ICU Medical. Under
Glenmark’s Trandolapril is an angiotensin converting enzyme inhibitor used to treat high blood pressure and is the generic equivalent of Mavik tablets marketed by Abbott Laboratories. This recent
As a result of the completion of this project, PreMD expects to enter into additional agreements with the company for further product development and other skin-testing initiatives. Brent
Strategic Growth International (SGI) will assist the company in establishing a stronger understanding of the investment opportunity AMDL represents while increasing the company’s awareness across global investment communities.
National Cancer Institute’s Bioinformatics Grid (caBIG) initiative is a network of infrastructure and tools that enables the collection, analysis and sharing of data and knowledge along the entire
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.